磷酸化核糖体S6激酶RSK2抗体

英文名称    Phospho-RSK2(Ser369)    

中文名称    磷酸化核糖体S6激酶RSK2抗体    

别    名    RPS6KA3(phospho S369); Rsk 2; MAPKAP Kinase 1b; MAP kinase activated protein kinase 1b; MAPK activated protein kinase 1b; 90 kDa ribosomal protein S6 kinase 3; HU2; HU3; Insulin stimulated protein kinase 1; ISPK1; MAPKAPK 1b; MAPKAPK1B; MRX19; p90 RSK3; p90RSK3; pp90RSK2; Ribosomal protein S6 kinase 90kDa polypeptide 3; Ribosomal protein S6 kinase alpha 3; Ribosomal S6 kinase 2; RPS6KA3; S6 kinase 2; S6K alpha3; KS6A3_HUMAN.    

磷酸化核糖体S6激酶RSK2抗体        

说 明 书    0.1ml      

产品类型    磷酸化抗体     

研究领域    肿瘤  免疫学  染色质和核信号  信号转导  细胞凋亡  转录调节因子  激酶和磷酸酶      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit,     

产品应用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    84kDa    

细胞定位    细胞核 细胞浆     

性    状    Lyophilized or Liquid    

浓    度    1mg/1ml    

免 疫 原    KLH conjugated Synthesised phosphopeptide derived from human RSK2 around the phosphorylation site of Ser369 [KD(p-S)PG]    

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

磷酸化核糖体S6激酶RSK2抗体 产品介绍    background:
RSK2 or MAPKAP Kinase 1b is a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains two non-identical kinase catalytic domains and phosphorylates various substrates including ribosomal protein S6 and members of the mitogen activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin Lowry syndrome. 

Function:
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3. Phosphorylates DAPK1.

Subunit:
Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in quiescent cells. Transiently dissociates following mitogenic stimulation (By similarity). Interacts with NFATC4, ETV1/ER81 and FGFR1.

Subcellular Location:
Nucleus. Cytoplasm.

Tissue Specificity:
Expressed in many tissues, highest levels in skeletal muscle.

Post-translational modifications:
Activated by phosphorylation at Ser-227 by PDPK1. Autophosphorylated on Ser-386, as part of the activation process. May be phosphorylated at Thr-365 and Ser-369 by MAPK1/ERK2 and MAPK3/ERK1. Can also be activated via phosphorylation at Ser-386 by MAPKAPK2.
N-terminal myristoylation results in an activated kinase in the absence of added growth factors. 

DISEASE:
Defects in RPS6KA3 are the cause of Coffin-Lowry syndrome (CLS) [MIM:303600]. A X-linked mental retardation associated with facial and digital dysmorphisms, progressive skeletal malformations, growth retardation, hearing deficit and paroxysmal movement disorders. 
Defects in RPS6KA3 are the cause of mental retardation X-linked type 19 (MRX19) [MIM:300844]. MRX19 is a non-syndromic form of mild to moderate mental retardation. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. In contrast to syndromic or specific X-linked mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation. 

Similarity:
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily.
Contains 1 AGC-kinase C-terminal domain.
Contains 2 protein kinase domains. 

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.    

磷酸化核糖体S6激酶RSK2抗体 

hz-0379R IL-6  白介素6抗体

hz-1811R IL-7  白介素7抗体

hz-1805R IL-6R alpha  白细胞介素6受体α抗体IL-6Rα

hz-1459R IL-6R Beta/CD130/gp130  白细胞介素6受体β抗体IL-6Rβ

hz-0780R IL-8/CXCL8  白介素8抗体

hz-1540R IL-7Ra/CD127  白细胞介素-7受体a抗体

hz-5395R phospho-IL-7Ra(Tyr449)  磷酸化白细胞介素-7受体a抗体

hz-1824R Mitofilin/IMMT  线粒体内膜蛋白抗体

hz-0317R ILK-1  整合素连接激酶-1抗体

hz-5443R phospho-ILK-1(Thr173)  磷酸化整合素连接激酶1抗体

hz-5444R phospho-ILK-1(Ser246)   磷酸化整合素连接激酶1抗体

hz-5445R phospho-ILK-1(Ser259)  磷酸化整合素连接激酶1抗体

hz-1291R ING1/p33  生长抑制因子基因1抗体

hz-1521R IGF2BP3/IMP3  胰岛素样生长因子ⅡmRNA结合蛋白3抗体

hz-1032R Inhibin Alpha  抑制素α抗体 Inhibin α

hz-1774R Inhibin beta A/Activin A  抑制素βA抗体 Inhibin βA

hz-1825R Inhibin beta B  抑制素βB/Inhibin β B抗体

hz-1826R Inhibin Beta C  抑制素βC抗体

hz-5074R Insig1  胰岛素诱导基因1抗体

hz-0056R Insulin  胰岛素抗体

hz-0862R Insulin  胰岛素抗体

hz-0855R Insulin  抗重组人胰岛素抗体

hzm-0862M Insulin(1D4:)  猪胰岛素单克隆抗体

hzm-0855M Insulin(1G11)  重组人胰岛素单克隆抗体

hz-0681R Insulin Receptor/CD220  胰岛素受体抗体

hz-0047R Insulin Receptor alpha  胰岛素受体α抗体

hz-0260R Insulin Receptor Alpha  胰岛素受体α抗体

hz-0290R Insulin Receptor Beta  胰岛素受体β抗体

hz-3492R Phospho-Insulin Receptor Beta(Tyr1345)  磷酸化胰岛素受体β抗体

hz-3493R Phospho-Insulin Receptor Beta(Tyr1361)  磷酸化胰岛素受体β抗体

hz-5453R Phospho-Insulin Receptor Beta(Tyr1185)  磷酸化胰岛素受体β抗体

hz-0789R Insulin  胰岛素蛋白抗体

hz-2093R Integrin alpha 3/CD49c  整合素α3抗体

hz-1057R Integrin Alpha 3 + Beta 1  整合素α3β1抗体(Integrin α3β1)

hz-2094R Integrin beta 5  整合素β5抗体

hz-2095R Integrin alpha 1/CD49a  整合素α1抗体

hz-1051R Integrin beta 7  整合素β7抗体